Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Friedman

Showing results (31-40 of 212) with videos related to

Pageof 22
Sort By:
Journal of the National Cancer Institute|October 18, 1989
Impact of third-party reimbursement on cancer clinical investigation: a consensus statement coordinated by the National Cancer InstituteM McCabe, M A Friedman
Cancer Treatment Reviews|June 1, 1978
Malignant pleural effusionsM A Friedman, E Slater
The New England Journal of Medicine|February 20, 1992
Progress against rare and not-so-rare cancersB A Chabner, M A Friedman
Important Advances in Oncology|January 1, 1988
Progress in the adjuvant therapy of large bowel cancerM A Friedman, J M Hamilton
Biochemical Pharmacology|December 15, 1976
Suppression of hepatic DMN demethylase activity by nitrososarcosine and other nitrosaminesM A Friedman, D B Couch
Toxicology and Applied Pharmacology|November 1, 1970
Stability of piperonyl butoxideM A Friedman, S S Epstein
Journal of Chromatography|July 1, 1979
High-performance liquid chromatography of 2,6- and 2,4-diaminotoluene, and its application to the determination of 2,4-diaminotoluene in urine and plasmaP D Unger, M A Friedman
Cancer Treatment Reviews|December 1, 1980
A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958)M A Friedman, R J Ignoffo
CA: a Cancer Journal for Clinicians|July 1, 1991
The role of chemotherapy in the management of primary breast cancerF A Dorr, M A Friedman
Cancer Chemotherapy and Pharmacology|January 1, 1982
Primary hepatocellular carcinoma. Present state of the disease and prospects for the futureC J Oon, M A Friedman
Pageof 22

Showing results (31-40 of 212) with videos related to

Sort By:
Pageof 22
Journal of the National Cancer Institute|October 18, 1989
Impact of third-party reimbursement on cancer clinical investigation: a consensus statement coordinated by the National Cancer InstituteM McCabe, M A Friedman
Cancer Treatment Reviews|June 1, 1978
Malignant pleural effusionsM A Friedman, E Slater
The New England Journal of Medicine|February 20, 1992
Progress against rare and not-so-rare cancersB A Chabner, M A Friedman
Important Advances in Oncology|January 1, 1988
Progress in the adjuvant therapy of large bowel cancerM A Friedman, J M Hamilton
Biochemical Pharmacology|December 15, 1976
Suppression of hepatic DMN demethylase activity by nitrososarcosine and other nitrosaminesM A Friedman, D B Couch
Toxicology and Applied Pharmacology|November 1, 1970
Stability of piperonyl butoxideM A Friedman, S S Epstein
Journal of Chromatography|July 1, 1979
High-performance liquid chromatography of 2,6- and 2,4-diaminotoluene, and its application to the determination of 2,4-diaminotoluene in urine and plasmaP D Unger, M A Friedman
Cancer Treatment Reviews|December 1, 1980
A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958)M A Friedman, R J Ignoffo
CA: a Cancer Journal for Clinicians|July 1, 1991
The role of chemotherapy in the management of primary breast cancerF A Dorr, M A Friedman
Cancer Chemotherapy and Pharmacology|January 1, 1982
Primary hepatocellular carcinoma. Present state of the disease and prospects for the futureC J Oon, M A Friedman
Pageof 22